1. Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized multicenter trial of metastatic breast cancer;Batist;Journal of Clinical Oncology,2001
2. Phase II study of doxorubicin versus epirubicin in advanced breast cancer;Brambilla;Cancer Treatment Reports,1986
3. Phase III trial of liposomal doxorubicin and cyclophosphamide compared with epirubicin and cyclophosphamide as first-line therapy for metastatic breast cancer;Chan;Annals of Oncology,2004
4. A prospective randomized phase III trial comparing combination chemotherapy with cyclophosphamide, fluorouracil and either doxorubicin or epirubicin;Journal of Clinical Oncology,1988
5. Weekly epirubicin versus doxorubicin as second line therapy in advanced breast cancer, a randomized clinical trial;Gasparini;American Journal of Clinical Oncology,1991